Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FR3HF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,378
Award facts
- Contract value 100% obligated
- $60,378.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $60,378.20. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by September 4, 2025. The vendor will perform from its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal healthcare systems, regularly supplies pharmaceutical products and medical supplies to support military and veteran healthcare operations through the DLA Medical Supply Chain. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a broad range of medications, vaccines, and medical supplies to support Defense Health Agency and other government healthcare customers worldwide. This particular delivery order for Ozempic, a diabetes medication, exemplifies the company's role in supplying critical brand-name pharmaceuticals across multiple therapeutic domains to federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FR3HF?
SPE2DB25FR3HF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FR3HF worth?
The government has obligated $60,378 on SPE2DB25FR3HF.
Is contract SPE2DB25FR3HF an order under another contract?
Yes. SPE2DB25FR3HF is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3HF competed?
The extent of competition for SPE2DB25FR3HF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award